Literature DB >> 14732317

Novel effect of voriconazole on conidiation of Aspergillus species.

Neeraja L Varanasi1, Inthumathi Baskaran, George J Alangaden, Pranatharthi H Chandrasekar, Elias K Manavathu.   

Abstract

Our previous studies of Aspergillus fumigatus showed that colonies that grew in the presence of voriconazole (VCZ) were characteristically white without pigmentation. We therefore investigated the effect of various triazoles on conidiation and pigmentation in four commonly isolated Aspergillus species and the results were compared with those obtained for polyene and echinocandin classes of antifungal drugs. Aspergillus cultures were grown on Sabouraud dextrose agar containing subinhibitory concentrations of the antifungal drugs; fungal colonies that grew in the presence of drug were examined microscopically for conidiation and the number of conidia per fungal colony was determined by haemocytometry. Voriconazole at 0.125-0.5 mg/l inhibited conidiation in A. fumigatus, Aspergillus flavus, Aspergillus niger and Aspergillus nidulans producing white colonies. The effect of voriconazole was concentration dependent and greater than 99% inhibition of conidiation was obtained in A. flavus at 0.5 mg/l. When the white colonies were subcultured on drug-free medium, they readily produced conidia and pigmentation indicating that the effect is reversible. Other triazoles such as itraconazole (ITZ) and posaconazole (PCZ) were poor inhibitors of conidiation. On the other hand, ravuconazole (RCZ) with structural similarity to voriconazole inhibited conidiation in A. fumigatus and A. flavus, but not in A. niger and A. nidulans. Amphotericin B (AMB), nystatin (NYS), caspofungin (CFG) and micafungin (MFG) showed no effect on conidiation. Varying ability among the triazoles to inhibit conidiation in Aspergillus species suggests that the mechanism of action may be unrelated to the well-known inhibition of p450-dependent 14alpha-sterol demethylase, and perhaps is due to direct or indirect effect on the formation of conidia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732317     DOI: 10.1016/j.ijantimicag.2003.05.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

Review 1.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

2.  Atypical Aspergillus flavus isolates associated with chronic azole therapy.

Authors:  Mary E Brandt; Lalitha Gade; Cindy B McCloskey; S Arunmozhi Balajee
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

3.  In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Guillermo Garcia-Effron; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 4.  Pharmacokinetic/pharmacodynamic profile of voriconazole.

Authors:  Ursula Theuretzbacher; Franziska Ihle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray.

Authors:  Baihong Guo; Tuanjie Che; Baoguang Shi; Lijun Guo; Yongsheng Yin; Lin Li; Jinming Wang; Dongwen Yan; Yirong Chen
Journal:  Can Urol Assoc J       Date:  2011-01-13       Impact factor: 1.862

6.  Voriconazole inhibits melanization in Cryptococcus neoformans.

Authors:  Luis R Martinez; Patricia Ntiamoah; Attila Gácser; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

7.  Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole.

Authors:  Isabel Faria-Ramos; Sofia Farinha; João Neves-Maia; Pedro Ribeiro Tavares; Isabel M Miranda; Letícia M Estevinho; Cidália Pina-Vaz; Acácio G Rodrigues
Journal:  BMC Microbiol       Date:  2014-06-11       Impact factor: 3.605

8.  FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure.

Authors:  Ana Pinto E Silva; Isabel Marcos Miranda; Joana Branco; Patricia Oliveira; Isabel Faria-Ramos; Raquel M Silva; Acácio Gonçalves Rodrigues; Sofia Costa-de-Oliveira
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.